Poultry Health Market By Drug Type (Vaccines, Feed Additives, Parasiticides, Anti-Infectives, Other Drugs), By Test Type (Laboratory Testing, Diagnostic Imaging) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026
Industry Outlook
The global poultry health market is expected to reach US$ 11,506.3 Mn by 2026, and exhibit steady compound annual growth rate of 7.1% during the forecast period from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with best genetic potential will not grow efficiently if they are diseased or infected. Infectious disease causing agents spread very quickly through the flock due to high stocking densities in poultry farms. Therefore, for effective poultry health management, the basic aim is prevention of infection or parasite onset, or discovery at an early stage; and early treatment. As the global population is consistently increasing, the demand for livestock and animal products is also correspondingly growing. Changing lifestyle, high demand for protein and lean foods has led to growing uptake of poultry food items. The poultry health market mainly comprises drugs and diagnostic tools used for ensuring poultry flock bred for consumption such as chicken, geese, ducks, turkey and so on.
"Impetus on Disease Prevention to render Dominant Status to Vaccines"
Meat consumers are becoming increasingly concerned about food safety. Several local and international standards have been put in place for avoiding undesirable substances in food derived from different animals. Evidence is also available suggesting that chicken is the most prominent carrier of microorganisms causing food poisoning in humans. Risk of infection from salmonella and campylobacter has been posing as a concern for both consumers and producers. Regulations have been formulated for preventing diseases in poultry birds and vaccines are opined to be crucial in providing immunity from infections. The demand for poultry vaccines is also driven by growing poultry production, greater government initiatives towards livestock immunization and human wellbeing and heightening demand for white meat. Technological evolution in vaccine manufacturing and growth in poultry healthcare spending are other prominent factors fueling the poultry vaccines market.
"Introduction of DNA Vaccines to Shape the Future Roadmap of the Global Market"
With the outbreak of critical diseases such as Newcastle disease, respiratory infections and avian influenza, poultry farmers are increasingly opting for preventive diagnosis of the flock. This not just ensures healthy production but also avoid catastrophic losses to farmers. Technological advancement has also led to introduction of novel vaccines in the market that were previously unavailable. For instance, Merck Animal Health has an active project involving the use of electron beam to inactivate Clostridium perfringens, which will create the novel vaccine to control necrotic enteritis in flock. In November 2017, the U.S. FDA granted approval to first DNA vaccine by AgriLabs for controlling avian influenza. Introduction of DNA vaccines has been opined to be a major milestone in realizing the importance of vaccines in poultry health. DNA vaccines have rapid response and can be manufactured faster than conventional counterparts, therefore to play a promising role during the forecast period.
"Laboratory Tests such as ELISA to Spearhead the Diagnostics Space"
Disease outbreaks, supportive government policies and technological advancements are the key factors that substantiate the pace of poultry diagnostics market. As the incidence of critical infection outbreaks such as of Newcastle disease, respiratory infections, salmonella infections and influenza is on the rise, poultry farmers worldwide are increasingly adopting preventive measures for maintaining poultry health. Outbreaks of such diseases compromise food safety and affect trade of birds and meat products, resulting in significant losses. As a result, continuous efforts are being undertaken to augment awareness in the poultry farmers about the available preventive measures. Laboratory tests currently hold the dominant position in the poultry diagnostics segment while capturing over 50% market share. High specificity, and accuracy, and their proven ability in controlling epidemic outbreaks are attributed to the dominance of this segment. Some of the prominent players in the poultry diagnostics segment are BioinGentech Biotechnology, Thermo Fisher Scientific, Biocheck Smart Veterinary Diagnostics, MEGACOR Diagnostik, IDEXX Laboratories, and others. New product development, rapid innovation in imaging technologies, mergers and acquisitions are the key growth measures observed in the poultry diagnostics market.
"Set to Remain the Leading Consumer of Meat Products, North America will Dominate the Market"
North America is the largest regional market for poultry health followed by Asia Pacific and Europe. The prominence of North America is mainly contributed by increasing domestic population, greater consumption of meat products, increasing preference to white and lean meat as against red meat. On the other hand, Asia Pacific will witness swift growth during the forecast period, with significant impact coming from key markets of China, Japan and India. The poultry industry in Asia Pacific has been witnessing growth like never before, as the market for protein-rich food is growing, there has been a consistently increasing demand for poultry meat and eggs. The exports of meat products from these regions are also high. Latin America will also undergo rapid market growth during the forecast period on grounds of improving awareness and growing demand for food from ever-growing population.
Historical & Forecast Period
This research report presents the analysis of each segment considered for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.
Trends in the global poultry health industry are assessed for understanding the current and future outlook of the market. Analysis of the market drivers, challenges and opportunities give insights in the positive arenas and pain points currently prevalent in the market. This report also includes profiles of key players operating in the global poultry health market. Companies are profiled based on parameters such as business overview, financial information, product portfolio and key developments. The key players currently engaged in the global poultry health market are Bayer AG (Bayer Animal Healthcare), Bimeda, Inc., Boehringer Ingelheim Animal Health, Ceva Animal Health, Inc., Eli Lily and Company (Elanco Animal Health), Merck & Company, Inc., Sanofi SA (Merial Animal Health), Virbac SA, Vetoquinol SA, and Zoetis, Inc.
Key questions answered in this report
- How the poultry health market stands in 2017?
- In which direction will the market progress throughout the forecast period from 2018 to 2016?
- What are the major factors driving and challenging the progress of the global poultry health market?
- How the current market movements are opening new opportunities in the global market?
- What are the key strategic initiatives being undertaken by major market players to augment or retain their positions?
- Which treatment type currently holds prominence in the global market and how the scenario will move during the forecast period?
- What impact will technological innovation and introduction of DNA vaccines will have on the global poultry health market?
- What are the key diagnostic methods adopted by poultry farmers?
- What is the current status of Asia Pacific market in the global poultry health market?
- How Latin America market is moving towards future growth?
- Will the market position of North America be challenged by Asia Pacific within the forecast period?
1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
2. Executive Summary
2.1. Global PH Market Portraiture
2.2. Global PH Drugs Market, by Drug Type, 2017 (US$ Mn)
2.3. Global PH Diagnostics Market, by Type, 2017 (US$ Mn)
2.4. Global PH Market Share, by Geography, 2017 (US$ Mn)
3. Global Poultry Health (PH) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.2.1. Growing Meat Consumption Worldwide
3.2.2. Driver 2
3.3. Challenges
3.3.1. Challenge 1
3.3.2. Challenge 2
3.4. Opportunities
3.4.1. Opportunity 1
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Analysis: Global PH Drugs Market, by Key Players, 2017
3.6.2. Competitive Analysis: Global PH Diagnostics Market, by Key Players, 2017
4. Global Poultry Health (PH) Drugs Market, by Drug Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Vaccines
4.3. Feed Additives
4.4. Parasiticides
4.5. Anti-infectives
4.6. Other Drugs (fumigants, multivitamins, etc.)
5. Global Poultry Health (PH) Diagnostics Market, by Test Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Laboratory Testing
5.2.1. ELISA
5.2.2. PCR
5.2.3. Others (serology, histopathology, etc.)
5.3. Diagnostic Imaging
6. Global Poultry Health (PH) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.1.1. North America PH Market, 2016-2026 (US$ Mn)
6.1.2. North America PH Drugs Market, by Drug Type, 2016 - 2026 (US$ Mn)
6.1.3. North America PH Diagnostics Market, by Test Type, 2016 - 2026 (US$ Mn)
6.1.4. North America PH Market, by Country, 2016 – 2026 (US$ Mn)
6.1.4.1. U.S.
6.1.4.2. Canada
6.2. Europe PH Market, 2016 – 2026 (US$ Mn)
6.2.1. Europe PH Drugs Market, by Drug Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe PH Diagnostics Market, by Test Type, 2016 - 2026 (US$ Mn)
6.2.3. Europe PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific PH Market, 2016 – 2026 (US$ Mn)
6.3.1. Asia Pacific PH Drugs Market, by Drug Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific PH Market, by Test Type, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America PH Market, 2016 – 2026 (US$ Mn)
6.4.1. Latin America PH Drugs Market, by Drug Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America PH Diagnostics Market, by Test Type, 2016 - 2026 (US$ Mn)
6.4.3. Latin America PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa PH Market, 2016 – 2026 (US$ Mn)
6.5.1. Middle East & Africa PH Drugs Market, by Drug Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa PH Diagnostics Market, by Test Type, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa PH Market Analysis, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
7. Company Profiles
7.1. PH Drugs
7.1.1. Bayer AG (Bayer Animal Healthcare)
7.1.1.1. Business Description
7.1.1.2. Financial Information (Subject to Data Availability)
7.1.1.3. Product Portfolio
7.1.1.4. Key Developments
7.1.2. Bimeda, Inc.
7.1.3. Boehringer Ingelheim Animal Health
7.1.4. Ceva Animal Health, Inc.
7.1.5. Eli Lily and Company (Elanco Animal Health)
7.1.6. Merck & Company, Inc.
7.1.7. Sanofi SA (Merial Animal Health)
7.1.8. Virbac SA
7.1.9. Vetoquinol SA
7.1.10. Zoetis, Inc.
7.2. PH Diagnostics
7.2.1. AffiniTech, Ltd.
7.2.2. BioChek Smart Veterinary Diagnostics
7.2.3. BioinGentech Biotechnology Company
7.2.4. Bioneer Corporation
7.2.5. IDvet
7.2.6. IDEXX Laboratories, Inc.
7.2.7. MEGACOR Diagnostik GmbH
7.2.8. QIAGEN
Note :
Modification in the list of company profiles or scope of the study can be incorporated on request.
* PH - Poultry Health
TABLE 1 Global Poultry Health (PH) Market Portraiture
TABLE 2 Global PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global PH Laboratory Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global PH Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn
TABLE 8 North America PH Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Europe PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn
TABLE 17 Latin America PH Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa PH Drugs Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa PH Diagnostics Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East and Africa PH Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 21 Bayer AG (Bayer Animal Healthcare): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bimeda, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Boehringer Ingelheim Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Ceva Animal Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Eli Lily and Company (Elanco Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Merck & Company, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Sanofi SA (Merial Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Virbac SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetoquinol SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Zoetis, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 AffiniTech, Ltd..: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 BioChek Smart Veterinary Diagnostics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 BioinGentech Biotechnology Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Bioneer Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 IDvet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 IDEXX Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 MEGACOR Diagnostik GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 QIAGEN: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG 1. Poultry Health (PH) Market: Research Methodology
FIG 2. PH: Market Segmentation
FIG 3. Global PH Drugs Market, by Type, 2017 (US$ Mn)
FIG 4. Global PH Diagnostics Market, by Type, 2017 (US$ Mn)
FIG 5. Global PH Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global PH Drugs Market, by Key Players, 2017
FIG 8. Competitive Analysis: Global PH Diagnostics Market, by Key Players, 2017
FIG 9. Global PH Vaccines Market, 2016-2026(US$ Mn)
FIG 10. Global PH Feed Additives Market, 2016-2026 (US$ Mn)
FIG 11. Global PH Parasiticides Market, 2016-2026 (US$ Mn)
FIG 12. Global PH Anti-infectives Market, 2016-2026 (US$ Mn)
FIG 13. Global PH Market for Other Drugs, 2016-2026 (US$ Mn)
FIG 14. Global PH ELISA Testing Market, 2016-2026 (US$ Mn)
FIG 15. Global PH PCR Testing Market, 2016-2026 (US$ Mn)
FIG 16. Global PH Other Laboratory Testing Market, 2016-2026 (US$ Mn)
FIG 17. Global PH Diagnostic Imaging Market, 2016-2026 (US$ Mn)
FIG 18. U.S. PH Market, 2016-2026 (US$ Mn)
FIG 19. Canada PH Market, 2016-2026 (US$ Mn)
FIG 20. U.K. PH Market, 2016-2026 (US$ Mn)
FIG 21. Germany PH Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Europe PH Market, 2016-2026 (US$ Mn)
FIG 23. China PH Market, 2016-2026 (US$ Mn)
FIG 24. Japan PH Market, 2016-2026 (US$ Mn)
FIG 25. India PH Market, 2016-2026 (US$ Mn)
FIG 26. Rest of Asia Pacific PH Market, 2016-2026 (US$ Mn)
FIG 27. Brazil PH Market, 2016-2026 (US$ Mn)
FIG 28. Mexico PH Market, 2016-2026 (US$ Mn)
FIG 29. Rest of Latin America PH Market, 2016-2026 (US$ Mn)
FIG 30. GCC PH Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Middle East and Africa PH Market, 2016-2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)